new glp 1 drugs in development Navigating the -tides: Medication-Assisted Weight Loss on the Forefront GLP-1 Receptor Agonists and Research
Description
lifestyle interventions and prescribed medications remain the evidence-based approach for type 2 diabetes
However, a similar level of reduction in low-density lipoprotein (LDL) cholesterol and apolipoprotein B was seen with both tirzepatide and dulaglutide [18]
One of the qualms about GLP1s is that they involve a weekly injection, and some people do not like needles
BMC Pediatr
Many of these incidents involved dosing errors that resulted in hospital visits
